Categories: Technology

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

 | Source: Constellation Software Inc.

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am.

The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), at 7:00 am EST on Monday, March 9, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the March 9, 2026 conference call to answer questions regarding the Company’s results.

To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference ID 8822692. A conference operator will create a queue and introduce each questioner. You can also hear the call using the link https://edge.media-server.com/mmc/p/w3iuus4d. A replay of the call can be accessed using the link https://edge.media-server.com/mmc/p/w3iuus4d for 12 months following the call.

About Constellation Software Inc.
Constellation Software acquires, manages and builds vertical market software businesses.

Contact:

Jamal Baksh
Chief Financial Officer
416-861-9677

GlobeNews Wire

Recent Posts

LATHAM & WATKINS ELECTS 22 NEW PARTNERS

Promotions from counsel include skilled practitioners advising clients across transactional, litigation, and regulatory matters.NEW YORK,…

14 minutes ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20,…

2 hours ago

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

February 20, 2026 16:49 ET  | Source: Bel Fuse Inc. WEST ORANGE, N.J., Feb. 20,…

2 hours ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

3 hours ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a…

3 hours ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or…

3 hours ago